HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 150.00
+1.50 (1.01%)
At close: Sep 17, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 19.53 billion as of September 17, 2026. Its market cap has increased by 110.08% in one year.
Market Cap
19.53B
Enterprise Value
18.06B
Revenue
321.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
150.00
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 19.53B, an increase of 253.82%. That is a compound annual growth rate of 176.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 19.53B | 69.64% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 44.28B |
| A-Top Health Biotech | 43.45B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.80B |
| Intelligene | 7.05B |
| Tripartite Therapeutics | 6.09B |
| Uwell Biopharma | 6.03B |
| Obigen Pharma | 5.38B |
| Pet Pharm Biotech | 3.10B |